Found 2 hits Enz. Inhib. hit(s) with Target = 'Coagulation factor XI' and Ligand = 'BDBM304179' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM304179
(2-(1-((4-carboxyphenyl)amino)- 3-cyclopropyl-1-oxo...)Show SMILES COc1cc(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)[n+]([O-])cc1-c1c(F)c(Cl)ccc1OC(F)F |$;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;;;$,(-5.33,3.18,;-5.33,1.64,;-4,.87,;-2.67,1.64,;-1.33,.87,;,1.64,;,3.18,;1.33,3.95,;2.87,3.95,;2.1,5.29,;1.33,.87,;1.33,-.67,;2.67,1.64,;4,.87,;4,-.67,;5.33,-1.44,;6.67,-.67,;6.67,.87,;5.33,1.64,;8,-1.44,;8,-2.98,;9.34,-.67,;-1.33,-.67,;,-1.44,;-2.67,-1.44,;-4,-.67,;-5.33,-1.44,;-5.33,-2.98,;-4,-3.75,;-6.67,-3.75,;-6.67,-5.29,;-8,-2.98,;-8,-1.44,;-6.67,-.67,;-6.67,.87,;-8,1.64,;-8,3.18,;-9.34,.87,)| Show InChI InChI=1S/C26H22ClF3N2O6/c1-37-21-11-19(32(36)12-17(21)22-20(38-26(29)30)9-8-18(27)23(22)28)16(10-13-2-3-13)24(33)31-15-6-4-14(5-7-15)25(34)35/h4-9,11-13,16,26H,2-3,10H2,1H3,(H,31,33)(H,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.310 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp.
US Patent
| Assay Description The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIa can be determined using a relevant purified serine... |
US Patent US10143681 (2018)
BindingDB Entry DOI: 10.7270/Q2348NG3 |
More data for this Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM304179
(2-(1-((4-carboxyphenyl)amino)- 3-cyclopropyl-1-oxo...)Show SMILES COc1cc(C(CC2CC2)C(=O)Nc2ccc(cc2)C(O)=O)[n+]([O-])cc1-c1c(F)c(Cl)ccc1OC(F)F |$;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;;;$,(-5.33,3.18,;-5.33,1.64,;-4,.87,;-2.67,1.64,;-1.33,.87,;,1.64,;,3.18,;1.33,3.95,;2.87,3.95,;2.1,5.29,;1.33,.87,;1.33,-.67,;2.67,1.64,;4,.87,;4,-.67,;5.33,-1.44,;6.67,-.67,;6.67,.87,;5.33,1.64,;8,-1.44,;8,-2.98,;9.34,-.67,;-1.33,-.67,;,-1.44,;-2.67,-1.44,;-4,-.67,;-5.33,-1.44,;-5.33,-2.98,;-4,-3.75,;-6.67,-3.75,;-6.67,-5.29,;-8,-2.98,;-8,-1.44,;-6.67,-.67,;-6.67,.87,;-8,1.64,;-8,3.18,;-9.34,.87,)| Show InChI InChI=1S/C26H22ClF3N2O6/c1-37-21-11-19(32(36)12-17(21)22-20(38-26(29)30)9-8-18(27)23(22)28)16(10-13-2-3-13)24(33)31-15-6-4-14(5-7-15)25(34)35/h4-9,11-13,16,26H,2-3,10H2,1H3,(H,31,33)(H,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.470 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp.
US Patent
| Assay Description The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIa can be determined using a relevant purified serine... |
US Patent US10143681 (2018)
BindingDB Entry DOI: 10.7270/Q2348NG3 |
More data for this Ligand-Target Pair | |